TABLET AND TABLET TECHNOLOGY
Achieves the drug release at different site absorption
improved efficacy & performance
Reduces adverse events
Increases convenience & patient compliance
MEDYRAB. ON TABLETS
WORKING TOGETHER FOR GREATER RELIEF
Rabeprazole 20mg (Delayed – Release) & Ondansetron 4mg (Immediate – release)
Ondansetron ANTIEMETIC
- Antagonizes 5HT-3 receptor both peripherally as well
- as centrally & block the initiation of the reflux
- Combination with PPIs has recently been
- introduced in market for the treatment of peptic
- ulcer, (GERD) and to prevent nausea
Reviews
There are no reviews yet.